Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 142,593 | 105,825 | 55,465 | N/A |
| Depreciation Amortization | N/A | 8,291 | 4,811 | 2,372 | N/A |
| Income taxes - deferred | N/A | 1,827 | -1,826 | -588 | N/A |
| Accounts receivable | N/A | -17,307 | -11,597 | -3,379 | N/A |
| Accounts payable and accrued liabilities | N/A | -5,635 | -536 | 613 | N/A |
| Other Working Capital | N/A | -49,431 | -7,079 | 13,806 | N/A |
| Other Operating Activity | 0 | 68,942 | 48,433 | 22,193 | 0 |
| Operating Cash Flow | $N/A | $149,280 | $138,031 | $90,482 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -9,653 | -8,098 | -5,265 | N/A |
| Net Acquisitions | N/A | -223,531 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -105,451 | -102,661 | -60,142 | N/A |
| Sale Of Investment | N/A | 339,865 | 113,032 | 56,846 | N/A |
| Investing Cash Flow | $N/A | $1,230 | $2,273 | $-8,561 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 47,156 | 6,362 | 791 | N/A |
| Common Stock Repurchased | N/A | -222,014 | -180,124 | -102,316 | N/A |
| Other Financing Activity | 0 | 5,109 | 592 | 14 | 0 |
| Financing Cash Flow | $N/A | $-169,749 | $-173,170 | $-101,511 | $N/A |
| Exchange Rate Effect | N/A | 964 | 392 | 504 | N/A |
| Beginning Cash Position | N/A | 104,073 | 104,073 | 104,073 | N/A |
| End Cash Position | N/A | 85,798 | 71,599 | 84,987 | N/A |
| Net Cash Flow | $N/A | $-18,275 | $-32,474 | $-19,086 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 149,280 | 138,031 | 90,482 | N/A |
| Capital Expenditure | N/A | -9,653 | -8,098 | -5,265 | N/A |
| Free Cash Flow | 0 | 139,627 | 129,933 | 85,217 | 0 |